{"id":1231,"date":"2021-03-05T15:31:00","date_gmt":"2021-03-05T23:31:00","guid":{"rendered":"https:\/\/www.radxrad.org\/?p=1231"},"modified":"2021-03-21T15:35:03","modified_gmt":"2021-03-21T22:35:03","slug":"coronavirus-covid-19-update-fda-issues-authorization-for-first-molecular-non-prescription-at-home-test","status":"publish","type":"post","link":"https:\/\/www.radxrad.org\/coronavirus-covid-19-update-fda-issues-authorization-for-first-molecular-non-prescription-at-home-test\/","title":{"rendered":"Coronavirus (COVID-19) Update: FDA Issues Authorization for First Molecular Non-Prescription, At-Home Test"},"content":{"rendered":"\n<p>Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the\u00a0Cue COVID-19 Test for Home and Over The Counter (OTC) Use. The product is a molecular nucleic acid amplification test (NAAT) that is intended to detect genetic material from SARS-CoV-2 virus present in the nostrils. The test is the first molecular test authorized for at-home use without a prescription.<\/p>\n\n\n\n<p><a href=\"https:\/\/www.fda.gov\/news-events\/press-announcements\/coronavirus-covid-19-update-fda-issues-authorization-first-molecular-non-prescription-home-test\" data-type=\"URL\" data-id=\"https:\/\/www.fda.gov\/news-events\/press-announcements\/coronavirus-covid-19-update-fda-issues-authorization-first-molecular-non-prescription-home-test\" target=\"_blank\" rel=\"noreferrer noopener\">Read more<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the\u00a0Cue COVID-19 Test for Home and Over The Counter (OTC) Use. The product is a molecular nucleic acid amplification test (NAAT) that is intended to detect genetic material from SARS-CoV-2 virus present in the nostrils. The test is the first molecular&hellip;<\/p>\n","protected":false},"author":2,"featured_media":1234,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-1231","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.radxrad.org\/wp-json\/wp\/v2\/posts\/1231","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.radxrad.org\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.radxrad.org\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.radxrad.org\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.radxrad.org\/wp-json\/wp\/v2\/comments?post=1231"}],"version-history":[{"count":1,"href":"https:\/\/www.radxrad.org\/wp-json\/wp\/v2\/posts\/1231\/revisions"}],"predecessor-version":[{"id":1235,"href":"https:\/\/www.radxrad.org\/wp-json\/wp\/v2\/posts\/1231\/revisions\/1235"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.radxrad.org\/wp-json\/wp\/v2\/media\/1234"}],"wp:attachment":[{"href":"https:\/\/www.radxrad.org\/wp-json\/wp\/v2\/media?parent=1231"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.radxrad.org\/wp-json\/wp\/v2\/categories?post=1231"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.radxrad.org\/wp-json\/wp\/v2\/tags?post=1231"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}